HIKAL
Back to Income Statement
|
HIKAL Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹70 Cr | ₹78 Cr | ₹160 Cr | ₹133 Cr | ₹84 Cr |
What is the latest Consolidated Net Profit of HIKAL ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹70 Cr |
Mar2023 | ₹78 Cr |
Mar2022 | ₹160 Cr |
Mar2021 | ₹133 Cr |
Mar2020 | ₹84 Cr |
How is Consolidated Net Profit of HIKAL Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹70 Cr | -11.20 | |
Mar2023 | ₹78 Cr | -51.16 | |
Mar2022 | ₹160 Cr | 20.55 | |
Mar2021 | ₹133 Cr | 57.68 | |
Mar2020 | ₹84 Cr | - |
Compare Consolidated Net Profit of peers of HIKAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
HIKAL | ₹4,292.1 Cr | -7.2% | -4.9% | 23.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,827.0 Cr | -3.1% | -3.9% | 12.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,931.0 Cr | -2.9% | -0.8% | 62.5% | Stock Analytics | |
CIPLA | ₹117,322.0 Cr | 1.1% | 0.3% | 1.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,116.0 Cr | -1.3% | -9.4% | -0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,752.0 Cr | -3.7% | -5.9% | 19.7% | Stock Analytics |
HIKAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
HIKAL | -7.2% |
-4.9% |
23.5% |
SENSEX | -2.9% |
-0.1% |
6.8% |
You may also like the below Video Courses